Liquidia Corporation's stock ($LQDA) surged after a positive appeals court ruling, leading to enthusiastic tweets from investors. The ruling is expected to result in 'easy' near-term catalysts, including the rejection of rehearing by the Federal Circuit, dissolution of regulatory stay, and a commercialization announcement. BTIG raised the price target to $29, citing affirmed IPR decisions on appeal and the YUTREPIA launch on track for mid-2024 or earlier.
BTIG out making positive comments on $LQDA price tgt goes to $29 Congrats to the Liquidians, well done! Liquidia Corporation (LQDA) Buy, $29 PT '793 IPR Decisions Affirmed on Appeal, Leaving YUTREPIA Launch On Track for Mid-2024 or Earlier. Increasing PT to $29 from $18.
Time to size up $LQDA even more.
$LQDA is now my largest position. While it’s always good to take profits, I suspect the name may get a bump from some “easy” near term catalysts (Fed Cir likely rejecting rehearing, dissolution of regulatory stay, commercialization announcement). I have added at various levels…
$LQDA victory lap. Merry Xmas
$LQDA BOOM goes the dynamite https://t.co/qZoVyN4jNM
$LQDA Liquidia positive appeals court ruling. https://t.co/vhDjfUDrCi